An ambiguous phenomenon of radiation and drugs: Recall reactions

Onkologie

Volumn 30, Issue 4, 2007, Pages 209-214

  Caloglu, M ^a   Yurut Caloglu, V ^a   Cosar Alas, R ^a   Saynak, M ^a   Karagol, H ^a   Uzal, C ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Dermatitis; Radiotherapy; Recall reactions

Indexed keywords

ALPHA2B INTERFERON; ANTIHISTAMINIC AGENT; BLEOMYCIN; CAPECITABINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; HYDROCORTISONE; HYDROXYUREA; IDARUBICIN; ISONIAZID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; PACLITAXEL; PYRAZINAMIDE; RIFAMPICIN; SIMVASTATIN; TAMOXIFEN; TRIMETREXATE; VINBLASTINE;

BLOOD VESSEL INJURY; BRAIN STEM; BRAIN STEM NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COLITIS; DERMATITIS; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHEMA; ESOPHAGITIS; GASTRITIS; HEART TAMPONADE; HUMAN; INFLAMMATION; LARYNGITIS; LYMPHANGITIS; MUCOSA INFLAMMATION; MYOSITIS; NECROSIS; OPTIC NEURITIS; PANNICULITIS; PERICARDIAL EFFUSION; PNEUMONIA; RADIATION DERMATITIS; RADIATION NECROSIS; RADIATION RECALL REACTION; RADIATION RESPONSE; REVIEW; STEM CELL; VAGINA DISEASE; VAGINAL NECROSIS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HISTAMINE ANTAGONISTS; HUMANS; NEOPLASMS; RADIODERMATITIS; RADIOTHERAPY, HIGH-ENERGY; RISK FACTORS;

EID: 33947598102     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099632     Document Type: Review

References (55)

1. D'Angio GJ, Farber S, Maddock CL: Potentiation of x-ray effects by actinomycin D. Radiology 1959;73:175-177.
2. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N: Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004;100(9):1793-1799.
3. Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, Stupp R, Van Houtte P, Dubois JB, Ozsahin M: Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005;31(7):555-570.
4. Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R: Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002;53(2):394-400.
5. Sears ME: Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065). Cancer Chemother Rep 1964;40:31-32.
6. Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE: Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 2005;61(1):169-174.
7. Kodym E, Kalinska R, Ehringfeld C, Sterbik-Lamina A, Kodym R, Hohenberg G: Frequency of radiation recall dermatitis in adult cancer patients. Onkologie 2005;28(1):18-21.
8. Mayer EG, Poulter CA, Aristizabal SA: Complications of irradiation related to apparent drug potentiation by adriamycin. Int J Radiat Oncol Biol Phys 1976;1(11-12):1179-1188.
9. Greco FA, Oldham RK: Adriamycin and radiation reactions. Ann Intern Med 1977;86(5):655-656.
10. Moore TN, Livingston R, Heilbrun L, Durrance FY, Tesh D, Hickman B, Bogardus C: An acceptable rate of complications in combined doxorubicin- irradiation for small cell carcinoma of the lung: A Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 1978;4(7-8):675-680.
11. Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J: Radiation recall - another call with tamoxifen. Acta Oncol 1999;38(7):955-959.
12. Camidge R, Price A: Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59(3):237-245.
13. Hellman S, Botnick LE: Stem cell depletion: an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys 1977;2(1-2):181-184.
14. Seymour CB, Mothersill C, Alper T: High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50(1):167-179.
15. Abadir R, Liebmann J: Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol) 1995;7(5):325-326.
16. Wright EG: Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 1998;74(6):681-687.
17. Badger J, Kang S, Uzieblo A, Srinivas S: Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment. J Clin Oncol 2005;23(28):7224-7225.
18. Yeo W, Leung SF, Johnson PJ: Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1997;33(4):698-699.
19. Stelzer KJ, Griffin TW, Koh WJ: Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1993;71(4):1322-1325.
20. Fontana JA: Radiation recall associated with VP-16-213 therapy. Cancer Treat Rep 1979;63(2):224-225.
21. Lampkin BC: Skin reaction to vinblastine. Lancet 1969;1(7600):891.
22. Castellano D, Hitt R, Cortes-Funes H, Romero A, Rodriguez-Peralto JL: Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000;18(3):695-696.
23. Cassady JR, Richter MP, Piro AJ, Jaffe N: Radiation-adriamycin interactions: preliminary clinical observations. Cancer 1975;36(3):946-949.
24. Bokemeyer C, Lampe C, Heneka M, Schabet M, Bamberg M, Kanz L: Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996;7(7):755-756.
25. Rosen G, Tefft M, Martinez A, Cham W, Murphy ML: Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma. Cancer 1975;35(3):622-630.
26. Steel GG: The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988;11(1):31-53.
27. Greco FA, Brereton HD, Kent H, Zimbler H, Merrill J, Johnson RE: Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 1976;85(3):294-298.
28. Aristizabal SA, Miller RC, Schlichtemeier AL, Jones SE, Boone ML: Adriamycin-irradiation cutaneous complications. Int J Radiat Oncol Biol Phys 1977;2(3-4):325-331.
29. Borroni G, Vassallo C, Brazzelli V, Martinoli S, Ardigo M, Alessandrino PE, Borroni RG, Franchini P: Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma. Am J Dermatopathol 2004;26(3):213-216.
30. Fakih MG: Gemcitabine-induced rectus abdominus radiation recall. JOP 2006;7(3):306-310.
31. Ristic B: Radiation recall dermatitis. Int J Dermatol 2004;43(9):627-631.
32. Smith KJ, Germain M, Skelton H: Histopathologic features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 2002;6(6):535-540.
33. Kundak I, Oztop I, Soyturk M, Ozcan MA, Yilmaz U, Meydan N, Gorken IB, Kupelioglu A, Alakavuklar M: Paclitaxel-carboplatin induced radiation recall colitis. Tumori 2004;90(2):256-258.
34. Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, Porter DL, Elstrom R, Tsai DE: Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leuk Lymphoma 2005;46(9):1313-1320.
35. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, Shipley W, Curran W: Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47(1):13-47.
36. Ma LD, Taylor GA, Wharam MD, Wiley JM: "Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993;187(2):465-467.
37. Newburger PE, Cassady JR, Jaffe N: Esophagitis due to adriamycin and radiation therapy for childhood malignancy. Cancer 1978;42(2):417-423.
38. Ortmann E, Hohenberg G: Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine. J Clin Oncol 2002;20(13):3029-3030.
39. Saif MW, Black G, Johnson M, Russo S, Diasio R: Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. Cancer Chemother Pharmacol 2006;58(6):771-775.
40. Wallenborn PA 3rd, Postma DS: Radiation recall supraglottitis. A hazard in head and neck chemotherapy. Arch Otolaryngol 1984;110(9):614-617.
41. Kennedy RD, McAleer JJ: Radiation recall dermatitis in a patient treated with dacarbazine. Clin Oncol (R Coll Radiol) 2001;13(6):470-472.
42. Culp LR, Pou AM, Jones DV, Bayouth J, Sanguineti G: A case of radiation recall mucositis associated with docetaxel. Head Neck 2004;26(2):197-200.
43. Vonessen CF, Kligerman MM, Calabresi P: Radiation and 5-fluorouracil: a controlled clinical study. Radiology 1963;81:1018-1027.
44. Fogarty G, Ball D, Rischin D: Radiation recall reaction following gemcitabine. Lung Cancer 2001;33(2-3):299-302.
45. Gabel C, Eifel PJ, Tornos C, Burke TW: Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol 1995;57(2):266-269.
46. Thomas R, Stea B: Radiation recall dermatitis from high-dose interferon alfa-2b. J Clin Oncol 2002;20(1):355-357.
47. Jaffe N, Paed D, Farber S, Traggis D, Geiser C, Kim BS, Das L, Frauenberger G, Djerassi I, Cassady JR: Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer 1973;31(6):1367-1373.
48. Chan RT, Au GK, Ho JW, Chu KW: Radiation recall with oxaliplatin: report of a case and a review of the literature. Clin Oncol (R Coll Radiol) 2001;13(1):55-57.
49. Schweitzer VG, Juillard GJ, Bajada CL, Parker RG: Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995;76(6):1069-1072.
50. Stein RS: Radiation-recall enteritis after actinomycin-D and adriamycin therapy. South Med J 1978;71(8):960-961.
51. Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF: Tamoxifen-induced radiation recall dermatitis. Breast J 2004;10(2):170-171.
52. Jolivet J, Landry L, Pinard MF, McCormack JJ, Tong WP, Eisenhauer E: A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections. Cancer Chemother Pharmacol 1987;20(2):169-172.
53. Extermann M, Vogt N, Forni M, Dayer P: Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol 1995;48(1):77-78.
54. Nemechek PM, Corder MC: Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1992;70(6):1605-1606.
55. Piroth MD, Krempien R, Wannenmacher M, Zierhut D: Radiation recall dermatitis from docetaxel. Onkologie 2002;25(5):438-440.